48 related articles for article (PubMed ID: 30547773)
1. Is neoadjuvant folfox an effective treatment only in a very selected favorable subgroup of locally advanced rectal cancer?
Riou O; Castan F; Conroy T
Cancer Radiother; 2024 Jun; ():. PubMed ID: 38871603
[No Abstract] [Full Text] [Related]
2.
Han Z; Song C; Li D; Zhu W; Sun J; Yao J; Gan W; Wang F; Yang X; Zhu L
J Cancer; 2024; 15(10):3140-3150. PubMed ID: 38706918
[TBL] [Abstract][Full Text] [Related]
3. Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients.
Cristóbal I; Santos A; Rubio J; Caramés C; Zazo S; Sanz-Álvarez M; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638487
[TBL] [Abstract][Full Text] [Related]
4. BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
Maccaroni E; Giampieri R; Lenci E; Scortichini L; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Ambrosini E; Berardi R
World J Clin Oncol; 2021 Jul; 12(7):565-580. PubMed ID: 34367929
[TBL] [Abstract][Full Text] [Related]
5. BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives.
Molinaro E; Andrikou K; Casadei-Gardini A; Rovesti G
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198203
[TBL] [Abstract][Full Text] [Related]
6. 3.0 T MRI IVIM-DWI for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer.
Hu H; Jiang H; Wang S; Jiang H; Zhao S; Pan W
Abdom Radiol (NY); 2021 Jan; 46(1):134-143. PubMed ID: 32462386
[TBL] [Abstract][Full Text] [Related]
7. Current options for the management of rectal cancer.
O'Neil BH; Tepper JE
Curr Treat Options Oncol; 2007 Oct; 8(5):331-8. PubMed ID: 18181024
[TBL] [Abstract][Full Text] [Related]
8. [Difference of colon cancer and rectal cancer-from the view of an oncological physician].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):321-3. PubMed ID: 20723426
[No Abstract] [Full Text] [Related]
9. Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
Lin Z; Liu J; Peng L; Zhang D; Jin M; Wang J; Xue J; Liu H; Zhang T
BMC Cancer; 2018 Dec; 18(1):1253. PubMed ID: 30547773
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
11. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical Surgery.
AlGizawy SM; Essa HH; Ahmed BM
Oncologist; 2015 Jul; 20(7):752-7. PubMed ID: 26040621
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer.
Koizumi M; Yamada T; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Hara K; Ohta K; Uchida E; Yoshida H
In Vivo; 2018; 32(4):937-943. PubMed ID: 29936483
[TBL] [Abstract][Full Text] [Related]
14. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
Murata A; Inoue T; Maeda K; Noda E; Nagahara H; Kubo N; Tanaka H; Muguruma K; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2623-5. PubMed ID: 21224659
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer.
Nong J; Gong Y; Guan Y; Yi X; Yi Y; Chang L; Yang L; Lv J; Guo Z; Jia H; Chu Y; Liu T; Chen M; Byers L; Roarty E; Lam VK; Papadimitrakopoulou VA; Wistuba I; Heymach JV; Glisson B; Liao Z; Lee JJ; Futreal PA; Zhang S; Xia X; Zhang J; Wang J
Nat Commun; 2018 Aug; 9(1):3114. PubMed ID: 30082701
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
